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We used electric pulses to permeabilize porcine stratum
corneum and demonstrate enhanced epidermal trans-
port of methylene blue, a water-soluble cationic dye.
Electrodes were placed on the outer surface of excised
full-thickness porcine skin, and methylene blue was
applied to the skin beneath the positive electrode; 1 ms
pulses of up to 240 V were delivered at frequencies of
20–100 Hz for up to 30 min. The amount of dye in a
skin sample was determined from absorbance spectra of
dissolved punch biopsy sections. Penetration depth and
concentration of the dye were measured with light and
fluorescence microscopy of cryosections. At an electric
exposure dose VT (applied voltage H frequency H pulse
width H treatment duration) of about 4700 Vs, there is
a threshold for efficient drug delivery. Increasing the
Topical drug administration has potential advantagesover oral, injection, or intravenous drug delivery.These advantages include convenience, noninvasiveness,minimal trauma induction, and avoidance of ‘‘first-pass’’degradation or metabolism in the gastrointestinal tract
or liver. Tightly localized administration is possible, and systemic
delivery can be achieved through absorption by the dermal blood
supply. The main barrier to cutaneous or transcutaneous drug delivery
is the impermeability of the stratum corneum (SC), the outermost
layer of the skin (Scheuplein and Bronaugh, 1983). If the integrity
of the SC is disrupted, the barrier to molecular transit may be
greatly reduced.
Cutaneous absorption may be increased by removal of the SC by
tape-stripping or dermabrasion, excimer laser ablation (Jacques et al,
1987), or vehicle (solvent-carrier) optimization and the use of penetra-
tion enhancers like dimethyl sulfoxide, oleic acid, and alcohols (Singh
and Singh, 1993; Berti and Lipsky, 1995). Disruption of the SC also
can be achieved by electroporation, i.e., the creation of penetration
sites by an electric field. These penetration sites, although not yet well
characterized, are thought to be aqueous pores of nanometer size
with lifetimes from milliseconds to seconds (Chang, 1992). Ions and
molecules move through induced gaps of the SC by diffusion and
electromotive or electroosmotic transport (Edwards and Langer, 1994;
Chizmadzhev et al, 1995; Edwards et al, 1995). Electroporation differs
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applied voltage or field application time resulted in
increased dye penetration. Transport induced by electric
pulses was more than an order of magnitude greater than
that seen following iontophoresis. We believe that the
enhanced cutaneous delivery of methylene blue is due
to a combination of de novo permeabilization of the
stratum corneum by electric pulses, passive diffusion
through the permeabilization sites, and electrophoretic
and electroosmotic transport by the electric pulses.
Pulsed electric fields may have important applications
for drug delivery in a variety of fields where topical drug
delivery is a goal. Key words: electroporation/iontophoresis/
photodynamic therapy/topical administration. J Invest Dermatol
111:457–463, 1998
from iontophoresis – the increased migration of ions or charged
molecules through the skin when an electrical potential gradient is
applied. The primary transdermal iontophoretic route seems to be
appendageal or intercellular through pre-existing pathways (Edwards
and Langer, 1994; Lee et al, 1996), or as a result of low-voltage (,5 V)
induced permeabilization of appendageal bilayers (Chizmadzhev et al,
1998). A third form of electroenhanced drug delivery, electro-
chemotherapy (Mir et al, 1995), refers to the local delivery of electric
pulses across a tumor following systemic drug administration, and
usually does not involve cutaneous or transcutaneous delivery.
Studies have described electroporation-enhanced transport of
molecules across skin, using heat-stripped SC or epidermis, mounted
between flow-through chambers (Bommannan et al, 1994; Prausnitz
et al, 1995; Vanbever and Pre´at, 1995; Pliquett et al, 1996). Animal
in vivo work has been reported using murine models to study the
electroporative delivery of drugs (Prausnitz et al, 1993), microspheres
(Hofmann et al, 1995), and DNA (Titomirov et al, 1991). Riviere’s
group has developed and used an isolated perfused porcine skin flap as
an in vitro model for drug transport studies (Riviere and Monteiro-
Riviere, 1991; Riviere et al, 1995). We chose pig skin as a model
because its structure and characteristics closely approximate those of
human skin (Bronaugh et al, 1982; Ferry et al, 1995; Steinstrasser and
Merkle, 1995). To simulate in vivo conditions we used full-thickness
skin with two electrodes attached to the skin surface; short, high
voltage pulses were used to permeabilize the SC.
Topical drug delivery has the potential for use in many applications,
including the localized delivery of anesthetics, antibiotics, steroids,
and chemotherapeutic agents. This technique should have particular
advantages in the field of photodynamic therapy, where localized rather
than systemic administration is a goal. We used the phenothiazinium
dye methylene blue (MB) in these studies because its color allows
visual observation of its location, its absorbance and fluorescence
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Figure 1. Schematic diagram of the system used to monitor skin
resistance and to deliver electric pulses.
properties permit spectroscopic detection, and its cationic nature
serves as a model for a number of photosensitizers currently under
investigation.1
MATERIALS AND METHODS
Skin Belly skin from domestic pigs was obtained from a local abattoir and a
cardiopulmonary research laboratory. Fresh samples, stored on ice, were used
within 48 h. Full-thickness 10 3 20 cm sections were washed and shaved with
electric clippers. Skin was placed, dermal side down, on Saran Wrap on ice.
Each skin section was typically used for 3–6 measurements; both electrodes
were placed on a previously unused region before resistance measurements or
pulsing began.
Experimental set-up (Fig 1) Ag-AgCl electrodes (diameter 5 8 mm, In
Vivo Metric, Healdsburg, CA) were attached (5 cm apart) to the skin with
adhesive electrode washers (In Vivo Metric); Signa Gel Saline electrode gel
(Parker Laboratories, Orange, NJ) was used to ensure a good electrical
connection. For drug delivery, a small piece of cotton soaked with 200 µl of
MB (Fisher Scientific, Fairlawn, NJ, 1% in ddH2O, 0.03 M) was placed in the
cavity of the active electrode.
Pre- and postpulse skin resistance was measured using continuous low voltage
(300 mV) 1000 Hz bipolar square waves from a Dynascan Model 3300 pulse
generator (Chicago, IL). A load resistor (4.7 kΩ) was placed in series with the
skin, and the voltage drop across the whole circuit (VO) or just across the skin
(VS) was measured by a recording digital oscilloscope (Fluke 99 Scopemeter
Series II, Everett, WA). Skin resistance (in kΩ) was approximated from the
formula RS 5 (VS 3 RL)/(VO – VS), where RS is the skin resistance and RL is
the load resistor. A skin sample was used only if the pretreatment resistance
equaled 5 kΩ or more.
Electroporation was carried out using a pulse generator (Model 345, Velonex,
Santa Clara, CA) delivering multiple unipolar square pulses up to 240 V, at
frequencies of 20–100 Hz with a 1 ms pulse width. The electric exposure dose
VT (in Vs) was calculated as V 3 f 3 τ 3 t (Liang et al, 1988) where V is the
applied voltage, T 5 f 3 τ 3 t is the field application time, f is the frequency
(Hz), τ is the pulse width (ms), and t is the treatment duration (s). Iontophoresis
was performed using 5 V direct current (0.19 and 0.32 mA per cm2 for 30 and
60 min, respectively) generated by a Hewlett-Packard 6236 A Triple Output
Power Supply.
1Johnson PG, Rideout DA, Camacho SH, Oseroff AR: Photodynamic
therapy using Victoria Blue-BO analogs: in vivo toxicity and efficacy toward
murine colo-26 and human FaDu tumors in mice. Photochem Photobiol 6359S:31S,
1994 (abstr.)
Optical density of dissolved-sample supernatant After treatment the skin
was rinsed to remove superficial dye. Full-thickness 5 mm punch biopsy samples
(mean weight 38.6 mg) were dissolved overnight in 1 ml Solvable (Packard
Instrument, Meriden, CT) at 37°C. Solutions were centrifuged, and absorbance
spectra of the supernatant fractions were recorded. This method of dye
quantitation is a modification of the technique reported by Bellnier et al (1997)
and Lilge et al (1997), whereby we used absorbance rather than fluorescence
spectroscopy to monitor drug levels. The extinction coefficient of MB in
Solvable (µ30,000 per cm per M at λ 5 598–600 nm) was determined from
an absorbance versus concentration plot (data not shown). Transport across the
skin surface was calculated as µg dye per cm2. Average flux (µg per cm2 per
min) was calculated as the amount of dye in µg transported across an area of
0.196 cm2 divided by t, the treatment duration. Data and error are presented
as mean 6 SD unless stated otherwise.
Light microscopy Full-thickness 1 cm2 biopsies were embedded in Tissue-
Tek O.C.T. compound (Miles, Elkhart, IN), and frozen in liquid nitrogen.
Photomicrographs of cryostat sections (10 µm) perpendicular to the skin surface
were prepared. Also, images were collected with a Dage MTI CCD72 camera
(Dage-MTI, Michigan City, IN) with a 615 nm long-pass filter, and processed
with Image 1 software (Universal Imaging, West Chester, PA). The dye was
quantitated by measuring the transmission at wavelengths . 615 nm for each
of 300 pixels along a line normal to the skin surface. Pixel number was
converted to depth in µm by calibration with a section of known dimensions;
pixel size 5 0.20 µm2 (0.45 3 0.45 µm).
Fluorescence microscopy Intensified digital fluorescence microscopy was
performed with a Zeiss Axiovert 35 inverted epifluorescence microscope with
a 200 W mercury arc lamp for illumination. Images were obtained with a Dage
MTI CCD72 camera and GenII Sys intensifier. MB fluorescence was excited
with 630 nm light2 from a 5 W argon laser (Spectra-Physics 164) pumping a
Spectra-Physics Model 375 dye laser using DCM dye (Exciton, Dayton, OH),
tuned to the appropriate wavelength by a birefringence filter, and was detected
using a 660 nm long-pass filter (Tuite and Kelly, 1993). Quantitation of
fluorescence intensity was made by averaging across a 20-pixel wide zone, at
each of 300 pixels along a band normal to the skin surface; pixel size 5 0.20 µm2.
RESULTS
MB blue staining depended on electrical conditions Following
MB application, skin was observed at 203 magnification under a
stereo microscope. With no electric field, very little staining of the
skin surface was seen, with some MB concentration in skin creases.
After iontophoresis (5 V, 0.3 mA per cm2, 60 min, VT 5 9000 Vs),
less than 10% of the skin surface was stained dark blue in a punctate
pattern, with the heaviest staining in follicles and around hair
shafts. Following electroporation (240 V, 40 Hz, 1 ms, 10–30 min,
5750–17,280 Vs) there was no follicular accentuation, and the entire
skin surface was stained blue (data not shown).
MB penetration into the epidermis was seen in cryosections
(Fig 2) Under passive diffusion conditions, no MB was observed
(Fig 2a). With pulsing at 3600 Vs the dye entered the SC (Fig 2b),
whereas at a higher dose of 7200 Vs MB penetration into both the
SC and the epidermis was seen (Fig 2c). Pulsing at 14,400 Vs produced
migration of MB through the SC, a high concentration of dye in the
epidermis, and the appearance of some dye in the dermis (Fig 2d).
The dark bands seen at the SC surface in Fig 2(b, d) are not due to
the presence of MB, but are dark areas that appear to be artifacts due
to density differences in the inhomogeneous skin. (Similar darker bands
can be seen at the edges of the SC in Fig 2a.)
MB penetration depends on electric exposure dose, particularly
field application time and voltage The amount of MB delivered
to the skin increased with field application time T (Table I) when
voltage, frequency, and pulse width were held constant. The rate of
increase of dye penetration for the mean absorbance values as a function
of T (Fig 3a), was fit by a sigmoidal relationship3 with a correlation
coefficient r2 5 0.956.4 When VT was held constant at 8640 Vs, the
amount of MB recovered increased exponentially5 as the voltage
increased (Fig 3b, r2 5 0.999). At a constant VT 5 7200, penetration
remained constant at frequencies of 20–60 Hz (124 6 97 µg per cm2,
2Aqueous MB has a broad absorbance band at 598–640 nm.
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Figure 2. Visualization of MB penetration. Photomicrographs (light
microscopy, 403) of frozen section biopsies of porcine skin following MB
application: (a) Control, MB applied to the skin surface for 30 min, no pulse;
(b) 200 V, 10 Hz, τ 5 1 ms, 30 min, 3600 Vs; (c) 100 V, 40 Hz, τ 5 1 ms,
30 min, 7200 Vs; (d) 200 V, 40 Hz, τ 5 1 ms, 30 min, 14,400 Vs. Scale bar: 50 µm.
n 5 14). At frequencies ù70 Hz, MB penetration increased significantly
(317 6 163 µg per cm2, n 5 9, p , 0.002, Fig 3c); however, at the
higher frequencies severe skin damage (e.g., blistering) was seen.
As VT increased from 576 to 17,280 Vs, transport increased from
µ10 to 50 µg per cm2 (Table I). MB average flux ranged from 2 to
10 µg per cm2 per min, with a mean value of 3.5 6 2.3 (n 5 45).
No correlation between flux and exposure time (or VT) was seen.
MB delivered by electroporation showed much greater
penetration than dye delivered by iontophoresis or passive
diffusion Following iontophoresis (5 V, 0.19 mA per cm2, 30 min,
VT 5 9000 Vs) or passive diffusion, no MB was detectable in the
samples (i.e., the optical density was , 0.01, no greater than background
values). At 0.32 mA per cm2 (5 V, 60 min, VT 5 18,000 Vs), virtually
no MB penetration into the SC was seen with microscopic examination
of cryosections.
Some of the changes induced by electroporation appeared to persist
after the electric pulses had stopped. Electroporation was carried out
(5760 Vs, 240 V, 40 Hz, 10 min) with no MB present. At various
times (0–30 min) following the conclusion of pulsing, MB was applied
to the skin for 30 min. At all postpulse application times, penetration
was significantly greater than with either 30 min passive diffusion with
no preapplication pulsing, or iontophoresis (p , 0.05, Table I). MB
penetration was also significantly higher when the drug was applied
immediately after pulsing than at 10, 20, or 30 min after pulsing. No
correlation was seen with MB levels and postpulse application times . 0.
Absorbance measurements of MB tissue levels correlate well
with light and fluorescence microscopy data Light microscopy
data (Fig 4a) show very little MB present in the biopsy section under
no-pulse conditions. As VT increases, there is increased penetration,
reflected by the greater total amount of dye present in the section
(area under the curve) and by the increased depth at which the
maximum concentration appears. Similar behavior is seen from the
3Y 5 ODmin 1 (ODmax – ODmin)/[1 1 e
(T50–x)/dx], where T50, the value
of X at Y 5 50%, is 19.5 6 1.3 (SD) s (95% confidence interval, 11.2–27.9 s).
4Specimens were held on ice during treatment. This was done primarily so
that degradation of the skin sample would be slowed. The actual surface
temperature of the tissue was 10°C (6 0.5°C). In order to validate our studies
carried out on ice, experiments were conducted using samples maintained at
room temperature. For room temperature skin, T50 5 18.2, a value within
one SD of the value seen for the cooled samples.
5The data are well fit by the expression ln(MB) 5 0.0171x – 3.53.
Figure 3. Total penetration of MB in a 5 mm punch biopsy, measured
as the absorbance of drug in Solvable supernatant. Penetration as a
function of the following. (a) Field application time: all samples were pulsed
at a constant voltage (240 V), frequency (40 Hz), and pulse width (1 ms) for
1–30 min. Various symbols represent individual experiments; for each
experiment, all absorbance values were normalized to the maximum optical
density recorded for that experiment; s, mean values; - - - -, sigmoidal fit.
(b) Voltage: all samples (8640 Vs) were pulsed at a constant frequency (40 Hz)
and pulse width (1 ms) at 60–240 V for 60–15 min; plotted as natural log
of absorbance versus voltage; - - - -, linear fit of exponential relationship.
(c) Frequency: samples were pulsed at a constant voltage and pulse width at
frequencies of 20–100 Hz for 6–30 min; mean value (6 SD)
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Table I. Quantitation of delivery of MBa
Field application VT Mean nd SD mg MB per Transport Average flux Aerage flux
time (s) (treatment (Vs) ODb,c g tissuee (µg per cm2) (µg per cm2 (µg per cm2
(duration in min) per min) per h)
2.4 (1) 576 0.181 2 0.16 0.050 9.8 9.84 591
4.8 (2) 1152 0.135 2 0.04 0.037 7.4 3.68 221
9.6 (4) 2304 0.173 6 0.07 0.048 9.4 2.36 142
14.4 (6) 3456 0.255 6 0.13 0.071 13.9 2.32 139
19.2 (8) 4608 0.414 6 0.20 0.114 22.5 2.82 169
24.0 (10) 5760 0.647 6 0.44 0.179 35.2 3.52 211
28.8 (12) 6912 0.807 4 0.23 0.223 43.9 3.66 220
36.0 (15) 8640 0.930 7 0.55 0.257 50.6 3.38 203
48.0 (20) 11520 0.827 3 0.46 0.229 45.0 2.25 135
72.0 (30) 17280 0.893 3 0.40 0.247 48.6 1.62 97
MEAN (6 SD) 3.54 (62.3) 213 (6139)
30 min (postpulse 5760 0.044 20 0.017 2.4 0.08 4.8
dye application)
30 min (passive 0 0.018 11 0.005 1.0 0.03 1.8
diffusion)
30 min (iontophoresis) 9000 NDf , 0.03 , 1.8
aAll samples were pulsed at a constant voltage (240 V), frequency (40 Hz), and pulse width (1 ms), for 1–30 min.
bOptical density was obtained from absorbance spectra of the supernatant from Solvable dissolved tissue samples.
cAt the 0.05 level, the means are significantly different (ANOVA analysis).
dn, number of experiments.
eThe amount of dye in the sample was estimated using an extinction coefficient ε 5 30,000 per M per cm (1 cm path width) and a molecular weight of 320. Biopsy weight 5 38.6
(6 3.3) mg.
fNot detectable.
MB fluorescence emission assay (Fig 4b). There is a small MB peak
seen with VT 5 0 in the first 10–20 µm, reflective of localization at
the surface of the SC. With increasing VT there is increased dye
penetration. Penetration was quantitated by integrating the area
under each curve. In a plot of the area versus VT (Fig 5) for both
fluorescence and transmittance data, similar behavior is noted: an
increase in area as a function of increasing VT. Fluorescence data
reflect the greater sensitivity of that method, as seen by the earlier rise
in penetration – between 900 and 1500 Vs – as compared with the
optical density data where the rise is not seen until the electrical
exposure dose exceeds 3600 Vs. Because of the inherent sensitivity of
fluorescence detection, this method is particularly effective with low
concentrations of the dye, whereas optical density assays are useful in
the higher concentration ranges.
Finally, we see in Fig 6 that the two methods of MB quantitation
using optical density as a criterion, i.e., concentration (via absorbance)
in Solvable supernatant and image analyses using transmitted light,
yield very similar behavior trends.
DISCUSSION
Epidermal delivery of MB is enhanced by the application of electric
pulses. Even at low electric exposure doses, MB transport was orders
of magnitude greater than that seen using iontophoresis or passive
diffusion. Enhanced MB penetration was also observed when the drug
was applied to the skin after pulsing. Good agreement among the
various assays was found.
When pulsed at a constant voltage, frequency, and pulse width,
transport increases as the field application time or electrical exposure
dose increases (Fig 3a, Table I). This relationship was best fit by a
sigmoidal curve. The fit was empirically, and not theoretically, derived,
and reflects the plateau in MB penetration seen in our system at field
application times . 24 s (VT 5 5760). At electric exposure doses
above that level, MB penetration may be somewhat impeded by tissue
saturation. More significantly, depletion of the drug in the donor
electrode undoubtedly contributes to the plateau.
The increase of MB transport shows a step jump at a threshold dose
between 3500 and 5800 Vs. If the sizes of pores are related to the
dose, a step jump might be expected to appear when the average pore
size becomes large enough to accommodate the molecule in question,
and diffusion and electromotive transport through long-term openings
begins to contribute to the total transport.
The difference in thresholds for resistance drop (Gallo et al, 1997)
and MB penetration probably reflect the criteria of different pore size
requirements for each respective case. Molecules of sizes smaller than
the pores created by a given dose are free to diffuse through the
permeabilized barrier in the absence of pulses, in addition to those
molecules driven through these pores during the pulses. The threshold
of about 4700 Vs for efficient MB transport is considerably higher
than that for small ion conductance in resistance measurements (200 Vs),
as expected, given the larger size of the MB molecule.
At plateau pulsing conditions (T 5 36 s, VT 5 8640 Vs), transport
increases exponentially as a function of pulse voltage (Fig 3b). This
exponential voltage dependence for transport differs from our
observation of changes in the skin’s electrical resistance as a function
of pulse voltage (Gallo et al, 1997). In that instance we found that
long-term electrical resistance of the skin decreased as the voltage of
the pulse increased, but this voltage-dependent decrease in skin
resistance reached a plateau at about a 75% drop in resistance. Yet MB
penetration continues to rise as the voltage increases (Fig 3b). This
discrepancy results from the fact that different aspects of the electro-
poration/transport phenomenon are being monitored. Resistance
measurements reflect permeabilization of the SC, implying the creation
or enlargement of openings through the SC through which electrolytes
flow. As resistance drops, voltage is redistributed across the SC and
other layers, reducing the voltage gradient across the SC and reducing
the probability that additional poration will occur. In transport measure-
ments, molecular flow continues to increase as the voltage increases,
due to the driving electrophoretic force. We assume that the amount
of MB transport is proportional to the probability of pore formation
as a consequence of the applied pulses, and is a function of the applied
electric energy of the pulse train. The electric energy of the pulse may
be expressed as V2T/R, where R is the electrical resistance between
electrodes. For simplicity’s sake we assume R to be constant throughout
the pulse train application. The probability of the applied energy
reaching the pore formation energy threshold ε0 5 (V0
2T9)/R is given
by the Boltzmann equation P 5 e(ε–ε0)/kT9, where k is the Boltzmann
constant and T9 is the absolute temperature. Because the experi-
mental data in Fig 3(b) were collected with VT 5 K, where K is
constant, then T 5 K/V. The Boltzmann equation may be written as
P 5 e(V–V0)C, where C is a constant for a given temperature. Plotting
[MB] against V, under the constraint of constant VT, will result in an
exponential dependence of [MB] on V.
VOL. 111, NO. 3 SEPTEMBER 1998 ELECTROPULSE-ENHANCED DRUG DELIVERY 461
Figure 4. Concentration of MB versus penetration depth. (a)
Concentration as measured by image analyses of transmitted light (.615 nm):
. . ., no pulse; ––, 1800 Vs, 10 Hz, 100 V; – – –, 18,000 Vs, 100 V, 100 Hz;
, 45,000 Vs, 250 V, 100 Hz. All at τ 5 1 ms for 30 min. (b) Concentration
as measured by fluorescence emission (630 nm excitation, detected using a
660 nm long-pass filter): . . ., no pulse; ––, 360 Vs, 20 V, 10 Hz; – – –,
900 Vs, 50 V, 10 Hz; , 1800 Vs, 100 V, 10 Hz. All at τ 5 1 ms for 30 min.
MB penetration does not depend on the pulse frequency between
20 and 60 Hz. Similarly, we have previously shown that the maximum
decrease in skin resistance is reached at a frequency of 30–50 Hz (Gallo
et al, 1997). At low exposure doses (VT 5 100 Vs) the resistance
decrease was shown to be a nonlinear function of pulse train frequency,
whereas at VT 5 300 Vs no frequency dependence was seen.
Permeabilization of the SC appears to be due to pore formation by
electric pulses, and recovery to pore resealing (Benz and Zimmerman,
1981; Pliquett et al, 1995). We expect the resealing time to be
determined by pore size and resilience of the lipid bilayers that make
up the bulk of the SC. The plateau value of 30–50 Hz for a long-
term resistance drop implies that the recovery time of the SC is in the
range of 20–33 ms. If a second pulse is delivered within this time, a
cumulative poration effect may be achieved, resulting in permanent
permeability changes. The steep increase of MB transport observed at
.60 Hz could be due to rapid delivery of consecutive pulses within
,20 ms, resulting in a cumulative effect (e.g., heating) that produces
severe skin damage. To minimize adverse skin effects, the majority of
our pulsing was carried out at 40 Hz.
Skin resistance recovers rapidly after each pulse as long as the
cumulative dose is kept below a threshold value (Gallo et al, 1997).
Permeabilization becomes long-term only after the skin has experienced
Figure 5. Total penetration of MB in biopsy sections as a function of
log VT (Vs). Penetration as measured by the integrated intensity (area under
the curve) from image analyses of fluorescence (j) and light transmittance (s).
Figure 6. Total amount of MB penetration as a function of electrical
exposure dose VT, as determined by the concentration (via absorbance) in
Solvable supernatant (u) and light transmittance of scanned images (s).
a sufficiently high exposure dose. Above this threshold the skin is
permeable for a time even after pulsing ceases. This implies that long-
term openings or pores are created. This hypothesis is supported by
our observation that enhanced MB penetration was seen when applied
to the skin after pulsing at an above-threshold dose (Table I).
Taken together, our results support the view (Bommannan et al,
1994; Chizmadzhev et al, 1995) that, under these conditions, molecular
transport takes place through a combination of forces. An initial
permeabilization (electroporation) is required for transport to begin;
above that threshold, continued pulsing results in enhanced transport,
probably due to electromotive forces (electrophoresis and electro-
osmosis). The importance of electropermeabilization as a factor in this
process is emphasized by the relatively poor penetration by iontophoresis
alone. Furthermore, transport cannot be attributed to ‘‘high voltage
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iontophoresis’’ (i.e., electromotive processes) alone, because penetration
of MB, applied to the skin only after pulsing, was enhanced due to
diffusion of the drug through persisting electropores (Table I). We
are now carrying out additional experiments using various physical
techniques to characterize the long-term response of skin to electric
fields.
In some ways comparing our results with others is problematic.
Prausnitz et al (1993) report that transdermal delivery of calcein, a
tetraanionic molecule (molecular weight 623), is enhanced in an in vivo
system using hairless rats. In their system, however, the equivalent
electric dose was about 280 Vs, and plasma levels were detected 30–
60 min after pulsing, reflecting systemic delivery (µ10 µg per cm2 per
h) via the blood supply at the epidermal–dermal boundary. Riviere
et al (1995) monitored the transport of luteinizing hormone releasing
hormone (molecular weight 1182) using a perfused porcine skin flap
and iontophoresis enhanced by 1–3 electroporative pulses. Delivery of
this cationic drug (2 µg per cm2 per h) was also assayed by measuring
the amount present in the vasculature. Topical drug administration can
be used for systemic delivery via the circulatory system or for localized
delivery (e.g., to the skin). The relative importance of transport into
or through the skin depends on the desired target. For example, if
insulin delivery is the goal, transcutaneous delivery would be necessary.
Because our interest at this time is primarily in delivery of drugs for
cutaneous photodynamic therapy, controlled delivery to the skin is
more desirable.
Furthermore, the bulk of work in the field of electroporation-
enhanced drug delivery uses diffusion chambers and heat-stripped or
dermatomed skin, and measures the amount of material traversing the
skin sample. We use intact full-thickness tissue with both electrodes
located on the SC surface, and monitor delivery to the skin, measuring
both the amount in the sample and the penetration depth. We believe
that our system more closely models any projected in vivo use; however,
a comparison of our results with some studies using a chamber apparatus
is informative. For example, Vanbever and Pre´at (1995) reported
transport of the cationic metoprolol (molecular weight 267) of up to
500 µg per cm2 per h with five pulses of 250 V and τ 5 620 ms
(VT 5 775 Vs), using a hairless rat skin (full-thickness) model. Prausnitz
et al (1995) saw enhanced flux of heparin (anionic, 5–30 KD) up to
500 µg per cm2 per h using heat-stripped human cadaver skin. In that
instance, .43,000 pulses (150–350 V, τ 5 1.9 ms, 12 Hz, VT . 28,000
Vs) were applied. Thus when electric pulse doses approximated those
used in this work, molecular flux was within an order of magnitude
of the values we report for MB. In most cases, however, electric pulse
doses used in previous studies were considerably less than those
reported herein.
Some adverse side-effects of electrically enhanced transdermal trans-
port are possible, and may include such events as pain sensation, burns,
local skin irritation, or sensitization reactions. Electric current applied
to the skin, however, is routinely used in a wide range of applications,
including iontophoresis, transcutaneous electrical nerve stimulation,
electromyography, and enhancement of wound and bone fracture
healing. Consequently there is an extensive body of literature dealing
with the biologic effects of electric current (Ledger, 1992; Prausnitz,
1996; Lee, 1997). Judicious selection of various parameters, including
voltage or current, pulse length, pulse frequency, and treatment
duration, must be used to minimize any adverse effects while main-
taining efficacy.
As previously mentioned, this work was initiated with the goal of
improving local delivery of photosensitizers. One of the major draw-
backs to the use of FDA-approved Photofrin in photodynamic therapy
is long-term (ù30 d) patient photosensitivity (Dougherty and Marcus,
1992) as a consequence of its systemic administration. The tissue levels
achieved with electric pulse enhanced delivery, 0.05–0.3 mg per gram
of tissue (Table I), are orders of magnitude greater than the levels
achieved 24 h after intravenous or intraperitoneal injection of various
hydrophilic porphyrin photosensitizers (Boyle and Dolphin, 1996).
Furthermore, with systemic drug delivery only about 0.1% of the drug
dose reaches the target area (Boyle and Dolphin, 1996); with pulsed
electric-field delivery virtually all of the drug is delivered to the target
region, it is delivered more quickly, and systemic toxicity and/or
metabolism is reduced.
We think that electroporation will have important applications in
the field of drug delivery, and we are continuing studies to optimize
the parameters for electric pulse enhanced transport. We suggest that
this system may serve as a model for electroenhanced epidermal or
transdermal transport in a variety of fields where topical drug delivery
is a goal.
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